Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.645 | 0.560 | 14 | 64257333 | synonymous variant | C/T | snv | 6.7E-02 | 6.3E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.040 | 0.500 | 4 | 2005 | 2018 | ||||||
|
0.645 | 0.560 | 14 | 64257333 | synonymous variant | C/T | snv | 6.7E-02 | 6.3E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.040 | 0.500 | 4 | 2005 | 2018 | ||||||
|
0.645 | 0.560 | 14 | 64257333 | synonymous variant | C/T | snv | 6.7E-02 | 6.3E-02 |
|
Neoplasms; Male Urogenital Diseases | 0.030 | 1.000 | 3 | 2012 | 2015 | ||||||
|
0.645 | 0.560 | 14 | 64257333 | synonymous variant | C/T | snv | 6.7E-02 | 6.3E-02 |
|
Neoplasms; Male Urogenital Diseases | 0.030 | 1.000 | 3 | 2012 | 2015 | ||||||
|
0.708 | 0.400 | 14 | 64295199 | intron variant | A/C;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.030 | 1.000 | 3 | 2009 | 2018 | ||||||||
|
0.708 | 0.400 | 14 | 64295199 | intron variant | A/C;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.030 | 1.000 | 3 | 2009 | 2018 | ||||||||
|
0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 0.667 | 3 | 2005 | 2014 | ||||||
|
0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 |
|
Neoplasms; Male Urogenital Diseases | 0.030 | 1.000 | 3 | 2009 | 2015 | ||||||
|
0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 0.667 | 3 | 2005 | 2014 | ||||||
|
0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 |
|
Neoplasms; Male Urogenital Diseases | 0.030 | 1.000 | 3 | 2009 | 2015 | ||||||
|
1.000 | 0.080 | 14 | 64214130 | intron variant | A/C;G;T | snv |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.800 | 1.000 | 2 | 2012 | 2017 | ||||||||
|
0.645 | 0.560 | 14 | 64257333 | synonymous variant | C/T | snv | 6.7E-02 | 6.3E-02 |
|
Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2009 | 2014 | ||||||
|
0.645 | 0.560 | 14 | 64257333 | synonymous variant | C/T | snv | 6.7E-02 | 6.3E-02 |
|
Musculoskeletal Diseases | 0.020 | 1.000 | 2 | 2012 | 2014 | ||||||
|
14 | 64236875 | intron variant | G/A;T | snv |
|
0.700 | 1.000 | 2 | 2016 | 2019 | |||||||||||
|
0.882 | 0.200 | 14 | 64338283 | non coding transcript exon variant | A/G | snv | 0.20 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2011 | 2017 | |||||||
|
0.708 | 0.400 | 14 | 64295199 | intron variant | A/C;T | snv |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2007 | 2008 | ||||||||
|
0.708 | 0.400 | 14 | 64295199 | intron variant | A/C;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2009 | 2011 | ||||||||
|
0.708 | 0.400 | 14 | 64295199 | intron variant | A/C;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2011 | 2018 | ||||||||
|
1.000 | 0.080 | 14 | 64213242 | intron variant | A/G | snv | 0.63 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.700 | 1.000 | 2 | 2018 | 2018 | |||||||
|
0.807 | 0.200 | 14 | 64301584 | splice region variant | C/A;T | snv |
|
Neoplasms | 0.020 | < 0.001 | 2 | 2014 | 2019 | ||||||||
|
0.807 | 0.200 | 14 | 64301584 | splice region variant | C/A;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||||
|
0.807 | 0.200 | 14 | 64301584 | splice region variant | C/A;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||||
|
0.807 | 0.200 | 14 | 64301584 | splice region variant | C/A;T | snv |
|
Neoplasms | 0.020 | < 0.001 | 2 | 2014 | 2019 | ||||||||
|
0.807 | 0.200 | 14 | 64301584 | splice region variant | C/A;T | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2018 | 2019 | ||||||||
|
0.641 | 0.600 | 14 | 64233098 | 3 prime UTR variant | C/T | snv | 0.31 | 0.33 |
|
Nervous System Diseases; Mental Disorders; Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2009 | 2012 |